tiprankstipranks
Advertisement
Advertisement

CRVS Stock Latest News

Corvus Pharmaceuticals reports Q2 EPS (19c), consensus (17c)
The FlyCorvus Pharmaceuticals reports Q2 EPS (19c), consensus (17c)
2d ago
CRVS
Corvus Pharmaceuticals Announces Board Leadership Transition
PremiumCompany Announcements
Corvus Pharmaceuticals Announces Board Leadership Transition
17d ago
8K
CRVS
Corvus Stockholders Approve Directors and Governance Proposals
PremiumCompany Announcements
Corvus Stockholders Approve Directors and Governance Proposals
2M ago
8K
CRVS
Buy Rating Reaffirmed on Corvus as Soquelitinib Data Strengthen Thesis; $27 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed on Corvus as Soquelitinib Data Strengthen Thesis; $27 Price Target Maintained
3M ago
CRVS
Corvus Pharmaceuticals Unveils Positive Phase 1 Dermatitis Results
PremiumCompany Announcements
Corvus Pharmaceuticals Unveils Positive Phase 1 Dermatitis Results
3M ago
8K
CRVS
Corvus Pharmaceuticals reports Q1 EPS (15c), consensus (15c)
PremiumThe FlyCorvus Pharmaceuticals reports Q1 EPS (15c), consensus (15c)
3M ago
CRVS
Corvus Pharmaceuticals Announces Board Changes and New Director
Premium
Company Announcements
Corvus Pharmaceuticals Announces Board Changes and New Director
4M ago
8K
CRVS
Apple upgraded, Qualcomm downgraded: Wall Street’s top analyst calls
Premium
The Fly
Apple upgraded, Qualcomm downgraded: Wall Street’s top analyst calls
4M ago
SR
CLX
Corvus Pharmaceuticals initiated with a Buy at Goldman Sachs
PremiumThe Fly
Corvus Pharmaceuticals initiated with a Buy at Goldman Sachs
4M ago
CRVS
Corvus Pharmaceuticals Bets Big on Soquelitinib Pipeline
PremiumCompany Announcements
Corvus Pharmaceuticals Bets Big on Soquelitinib Pipeline
5M ago
CRVS
Corvus Pharmaceuticals Expands Equity Sales Capacity to $200 Million
PremiumCompany Announcements
Corvus Pharmaceuticals Expands Equity Sales Capacity to $200 Million
5M ago
8K
CRVS
Corvus Pharmaceuticals price target raised to $33 from $32 at Oppenheimer
PremiumThe Fly
Corvus Pharmaceuticals price target raised to $33 from $32 at Oppenheimer
5M ago
CRVS
Corvus Pharmaceuticals files automatic mixed securities shelf
PremiumThe FlyCorvus Pharmaceuticals files automatic mixed securities shelf
5M ago
CRVS
Corvus Pharmaceuticals: Strengthened Cash Runway and Expanding Soquelitinib Pipeline Underpin Buy Rating and Attractive Risk‑Reward Profile
Premium
Ratings
Corvus Pharmaceuticals: Strengthened Cash Runway and Expanding Soquelitinib Pipeline Underpin Buy Rating and Attractive Risk‑Reward Profile
5M ago
CRVS
Corvus Pharmaceuticals reports Q4 EPS (15c), consensus (13c)
Premium
The Fly
Corvus Pharmaceuticals reports Q4 EPS (15c), consensus (13c)
5M ago
CRVS
Corvus Pharmaceuticals options imply 7.9% move in share price post-earnings
PremiumThe Fly
Corvus Pharmaceuticals options imply 7.9% move in share price post-earnings
5M ago
CRVS
Corvus’ Soquelitinib Trial Completion Adds a New Catalyst in the Atopic Dermatitis Market
PremiumCompany Announcements
Corvus’ Soquelitinib Trial Completion Adds a New Catalyst in the Atopic Dermatitis Market
5M ago
CRVS
Corvus Advances Soquelitinib Into Phase 2 Eczema Trial: What Investors Should Watch
PremiumCompany Announcements
Corvus Advances Soquelitinib Into Phase 2 Eczema Trial: What Investors Should Watch
5M ago
CRVS
Corvus Pharmaceuticals options imply 5.5% move in share price post-earnings
PremiumThe Fly
Corvus Pharmaceuticals options imply 5.5% move in share price post-earnings
5M ago
CRVS
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsCRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
CRVS
3 ‘Strong Buy’ Biotech Stocks to Buy Now, 1/29/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, 1/29/2026, According to Top Analysts
6M ago
CRVS
NRIX
Corvus Pharmaceuticals price target raised to $30 from $20 at Mizuho
Premium
The Fly
Corvus Pharmaceuticals price target raised to $30 from $20 at Mizuho
6M ago
CRVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >